Groundbreaking Obesity Treatment Webinar for Pharmacists Announced for March 18

A new webinar on obesity treatment will take place on Wednesday, March 18, at 8:00 PM. Titled Obesity Update 2026: Innovative Treatment Approaches, Current Research, and Practical Knowledge for Pharmacies, the event is designed exclusively for pharmacists. Registration requires confirmation of professional status under German law.

Obesity is now recognised as a chronic disease with serious physical, psychological, and social effects. Yet public perception often wrongly frames it as a lifestyle choice or personal failure. This misunderstanding can delay proper treatment and ignore the condition's complex biology.

The webinar will explore cutting-edge therapies, including drugs like Mounjaro (tirzepatide, Lilly). These medications mimic natural hormones to regulate appetite, satiety, and metabolism in ways older treatments could not. Research shows high efficacy, but questions remain about lifelong use, limitations, and long-term effects.

Dr. Dennis Ballwieser, both a physician and an obesity patient, will speak about the impact of stigma. His personal experiences aim to highlight the need for respectful communication in healthcare. The event will also cover practical topics such as training patients to use injection pens, improving treatment adherence, and managing nutrient deficiencies.

Pharmacists play a key role in obesity care, acting as guides for patients throughout treatment. The webinar will stress interdisciplinary collaboration with medical practices to ensure better support.

The session will provide pharmacists with updated knowledge on obesity management. Topics range from new drug therapies to hands-on patient support. Registration remains open to qualified professionals under the German Medicinal Products Advertising Act.